Eloxx Pharmaceuticals ELOX
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2026Q1 | 101.09 | -3,795 | -4 | |||
| 2025Q1 | 71.5 | -1,222 | -2 | |||
| 2023Q4 | 139.33 | -4,028 | -3 | |||
| 2023Q3 | 101.25 | -3,637 | -4 | |||
| 2023Q2 | 95.37 | -21.45 | -4,140 | -4 | ||
| 2023Q1 | 88.01 | -31.68 | -5,483 | -6 | ||
| 2022Q4 | 95.39 | -33.55 | -6,028 | -6 | ||
| 2022Q3 | 95.13 | -36.65 | -7,142 | -8 | ||
| 2022Q2 | 96.97 | -54.03 | -10,296 | -11 | ||
| 2022Q1 | 94.26 | -58.96 | -10,953 | -12 | ||
| 2021Q4 | 96.2 | -45.67 | -11,630 | -12 | ||
| 2021Q3 | 103.64 | -4.4 | -10,245 | -10 | ||
| 2021Q2 | 99.09 | -272.8 | -35,729 | -36 | ||
| 2021Q1 | 96.78 | -96.8 | -8,414 | -9 | ||
| 2020Q4 | 94.76 | -66 | -5,806 | -6 | ||
| 2020Q3 | 95.15 | -74.8 | -6,296 | -7 | ||
| 2020Q2 | 96.18 | -83.6 | -7,586 | -8 | ||
| 2020Q1 | 98.72 | -154 | -13,767 | -14 | ||
| 2019Q4 | 98.75 | -127.6 | -11,488 | -12 | ||
| 2019Q3 | 99.25 | -140.8 | -12,779 | -13 |